# FDA Inspection 662811 - AstraZeneca LP - May 17, 2010

Source: https://www.keypedia.com/records/fda_inspections/astrazeneca-lp/37abc164-d2fe-4027-acf1-c427d6bfa644
Source feed: FDA_Inspections

> FDA Inspection 662811 for AstraZeneca LP on May 17, 2010. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 662811
- Company Name: AstraZeneca LP
- Inspection Date: 2010-05-17
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 979534 - 2016-04-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-lp/255c25f1-b9cf-4f9d-bd3b-208943e39c98)
- [FDA Inspection 888632 - 2014-07-23](https://www.keypedia.com/records/fda_inspections/astrazeneca-lp/55e6c1f5-7e9c-4a58-88a7-d58b5f8df77f)
- [FDA Inspection 786512 - 2012-06-14](https://www.keypedia.com/records/fda_inspections/astrazeneca-lp/f58c7309-fd1b-41ae-8f1b-5955eeeed839)
- [FDA Inspection 722306 - 2011-04-27](https://www.keypedia.com/records/fda_inspections/astrazeneca-lp/894f73e4-e4f1-42c4-9b0c-21c2df7abe58)

Company: https://www.keypedia.com/companies/astrazeneca-lp/aed77fd7-665b-4d39-96b1-13c588ef3a24

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c